SLC10A7 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.599800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.279800E-01
Normal-vs-Stage2
7.663600E-01
Normal-vs-Stage3
1.561600E-01
Normal-vs-Stage4
6.426200E-01
Stage1-vs-Stage2
1.418190E-01
Stage1-vs-Stage3
5.383600E-02
Stage1-vs-Stage4
9.631000E-01
Stage2-vs-Stage3
2.267000E-01
Stage2-vs-Stage4
2.558200E-01
Stage3-vs-Stage4
1.235050E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.352800E-01
Normal-vs-AfricanAmerican
9.132000E-01
Normal-vs-Asian
7.281200E-01
Caucasian-vs-AfricanAmerican
5.227000E-01
Caucasian-vs-Asian
8.482000E-01
AfricanAmerican-vs-Asian
5.611000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.896200E-01
Normal-vs-Female
7.301400E-01
Male-vs-Female
9.416600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.599000E-01
Normal-vs-Age(41-60Yrs)
9.930600E-01
Normal-vs-Age(61-80Yrs)
6.525200E-01
Normal-vs-Age(81-100Yrs)
7.490000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.749000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.795600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.499400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.237210E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.918600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.322600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.512400E-01
Normal-vs-Daily Drinker
3.927800E-01
Normal-vs-Weekly Drinker
4.662200E-01
Normal-vs-Occasional Drinker
8.725400E-01
Normal-vs-Social Drinker
8.513200E-01
Non Drinker-vs-Daily Drinker
3.142400E-01
Non Drinker-vs-Weekly Drinker
4.006000E-01
Non Drinker-vs-Occasional Drinker
2.343400E-01
Non Drinker-vs-Social Drinker
6.490800E-01
Daily Drinker-vs-Weekly Drinker
9.959600E-01
Daily Drinker-vs-Occasional Drinker
6.698400E-02
Daily Drinker-vs-Social Drinker
2.233000E-01
Weekly Drinker-vs-Occasional Drinker
1.276620E-01
Weekly Drinker-vs-Social Drinker
3.061000E-01
Occasional Drinker-vs-Social Drinker
5.467800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.111030E-01
Normal-vs-Grade 2
1.451650E-02
Normal-vs-Grade 3
1.865780E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.264600E-01
Grade 1-vs-Grade 3
7.972000E-01
Grade 1-vs-Grade 4
1.111030E-01
Grade 2-vs-Grade 3
7.709400E-01
Grade 2-vs-Grade 4
1.451650E-02
Grade 3-vs-Grade 4
1.865780E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.300400E-01
Normal-vs-NonDiabetic
6.258200E-01
Diabetic-vs-NonDiabetic
9.294400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.320400E-01
Normal-vs-NoPancreatitis
6.313000E-01
Pancreatitis-vs-NoPancreatitis
9.503200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.689800E-01
Normal-vs-N1
7.821200E-01
N0-vs-N1
9.056000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.829800E-01
Normal-vs-TP53-NonMutant
9.321800E-01
TP53-Mutant-vs-TP53-NonMutant
8.988800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
